Companies /Healthcare

Mannkind Corp

NASDAQ: MNKD Biotechnology
$3.95
▼ $0.11 (−2.71%) today
Markets closed · 10:42pm ET

MNKD Coverage

Page 20
9:27am ET
Investing

Top Day Trader Alerts (GE, PALM, VVUS, OREX, ARNA, MNKD)

Here are Wednesday’s top day trader and active trader alerts with more detailed trading volume and price analysis in the links over at VSInvestor.com: General Electric Co. (NYSE:GE) is challenging post-crash highs…

Douglas A. McIntyre
9:55am ET
Health and Healthcare

MannKind Raises Over $50 Million (MNKD, PFE)

MannKind Corporation (NASDAQ: MNKD) is getting hit after the company announced that it priced a secondary offering of 7,400,000 shares of its common stock.  While the press release does not say what…

Douglas A. McIntyre
4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre